Literature DB >> 30989683

Aspirin resistance mediated by oxidative stress-induced 8-Isoprostaglandin F2.

Juan Guo1, Jue Wang1, Juan Feng1.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Aspirin resistance refers to a patient's poor response to aspirin. There are many factors that can contribute to aspirin resistance, including single-nucleotide polymorphisms, medication compliance, drug-drug interactions and inflammation. COMMENT: Recently, oxidative stress-induced 8-isoprostaglandin F2α has attracted considerable attention because it is considered as a mechanism of aspirin resistance in many diseases, including coronary artery disease, neurology system disease, metabolic syndrome, cancer, chronic obstructive pulmonary disease and chronic kidney disease. In these diseases, increased oxidative stress may promote platelet activation and reduce the efficacy of aspirin by producing excessive amounts of 8-isoprostaglandin F2α. WHAT IS NEW AND
CONCLUSION: Given the wide clinical use of aspirin, it is essential to understand why some patients do not response to it. This article reviews current research on aspirin resistance mediated by oxidative stress-induced 8-isoprostaglandin F2α.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  8-isoprostaglandin F2α; aspirin resistance; cardiovascular and cerebrovascular disease; oxidative stress; platelet activation; thromboxane A2

Year:  2019        PMID: 30989683     DOI: 10.1111/jcpt.12838

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  6 in total

1.  Long Non-Coding RNA H19 Positively Associates With Aspirin Resistance in the Patients of Cerebral Ischemic Stroke.

Authors:  Jue Wang; Bin Cao; Yan Gao; Dong Han; Haiping Zhao; Yuhua Chen; Yumin Luo; Juan Feng; Yanxia Guo
Journal:  Front Pharmacol       Date:  2020-09-25       Impact factor: 5.810

2.  Efficacy of nifedipine tablets plus aspirin in patients with gestational hypertension and the effect on coagulation function and hemorheology.

Authors:  Xuejing Yin; Zhanhui Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 3.  Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases.

Authors:  Yixi Zhao; Shengjie Yang; Min Wu
Journal:  Front Pharmacol       Date:  2021-12-17       Impact factor: 5.810

4.  Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism - results from clinical observation studies.

Authors:  Marina Panova-Noeva; Bianca Wagner; Markus Nagler; Thomas Koeck; Vincent Ten Cate; Jürgen H Prochaska; Stefan Heitmeier; Imke Meyer; Christoph Gerdes; Volker Laux; Stavros Konstantinides; Henri M Spronk; Thomas Münzel; Karl J Lackner; Kirsten Leineweber; Hugo Ten Cate; Philipp S Wild
Journal:  EBioMedicine       Date:  2020-09-10       Impact factor: 8.143

5.  Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia.

Authors:  Cristina Barale; Franco Cavalot; Chiara Frascaroli; Katia Bonomo; Alessandro Morotti; Angelo Guerrasio; Isabella Russo
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

6.  Assessment of Risk Factors for Drug Resistance of Dual Anti Platelet Therapy After PCI.

Authors:  Lijie Zhang; Ying Lv; Jianyu Dong; Nana Wang; Zhan Zhan; Yuan Zhao; Shanshan Jiang
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.